Medical Cannabis Market is Projected to Increase at a Considerable Rate with COVPosted by Apeksha on August 6th, 2021 Global Medical Cannabis Market Trends, Growth and Size Analysis By Product form (Powders, Solids, Ointments and creams, Oil, Others), By Derivative (Cannabidiol, Tetrahydrocannabinol), By Application (Arthritis, Cancer, Alzheimer’s Disease, Others) and By Distribution Channel (Retail pharmacy, Online stores, Others) – Forecast to 2027 Market Overview The global medical cannabis market is anticipated to acquire a market value of USD 52.35 billion while thriving at a CAGR of 15.4% during the forecast period, anticipated Market Research Future (MRFR). Medical cannabis is the most commonly prescribed treatment for cancer, arthritis, and others. The increasing approval for medical cannabis products is anticipated to be a significant factor that can grow the market during the forecast period. The increasing R&D activities and the rising incidents of chronic ailments among expanding populace are anticipated to grow the market in the coming time. Regional Analysis As per the assessment conducted by MRFR, the Americas is anticipated to be the largest market share during the forecast period. The increasing participation of players in the region is likely to make a significant contribution to developing the market of North America. Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/medical-cannabis-market-8368 Key Players Some of the renowned players of the global medical cannabis market are Aphria, Inc. (Canada), Canopy Growth Corporation (Canada), Maricann Inc. (Canada), GW Pharmaceuticals PLC (UK), Tilray (Canada), Medical Marijuana, Inc. (US), Aurora Cannabis (Canada), Cannabis Sativa Inc. (US), CanniMed Ltd (Canada), United Cannabis (US), MediPharm Labs (Canada), and GBSciences Inc. (US). Contact: Akash Anand Market Research Future +1 646 845 9312 Like it? Share it! More by this author |